VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,142,798 | -14.6% | 762,305 | +123.6% | 0.00% | 0.0% |
Q2 2023 | $8,362,325 | -41.1% | 340,902 | -44.1% | 0.00% | 0.0% |
Q1 2023 | $14,188,069 | +9.9% | 609,715 | +19.6% | 0.00% | 0.0% |
Q4 2022 | $12,904,378 | +53.5% | 509,853 | +16.9% | 0.00% | 0.0% |
Q3 2022 | $8,408,000 | +67.6% | 436,090 | +121.4% | 0.00% | 0.0% |
Q2 2022 | $5,016,000 | -61.1% | 196,944 | -60.7% | 0.00% | 0.0% |
Q1 2022 | $12,890,000 | +1.3% | 501,179 | +64.9% | 0.00% | 0.0% |
Q4 2021 | $12,725,000 | +47.0% | 303,905 | +52.8% | 0.00% | 0.0% |
Q3 2021 | $8,656,000 | -21.7% | 198,883 | -14.9% | 0.00% | 0.0% |
Q2 2021 | $11,048,000 | +20.5% | 233,674 | +30.7% | 0.00% | 0.0% |
Q1 2021 | $9,166,000 | +647.6% | 178,786 | +290.5% | 0.00% | – |
Q4 2020 | $1,226,000 | +42.9% | 45,788 | +83.2% | 0.00% | – |
Q3 2020 | $858,000 | -54.8% | 24,987 | -46.1% | 0.00% | – |
Q2 2020 | $1,899,000 | +3118.6% | 46,356 | +2587.3% | 0.00% | – |
Q1 2020 | $59,000 | +321.4% | 1,725 | +54.6% | 0.00% | – |
Q4 2019 | $14,000 | – | 1,116 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |